Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back
View Session

Adult ID

Global ID

Pediatric ID
Meet-the-Professor

110 - Updates in the Management of Leprosy

Friday, October 18, 2024
8:00 AM – 9:00 AM US PT
Location: 404 AB

On Demand Live Streamed
All relevant financial relationships have been mitigated.


CME Credits: Maximum of 1 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1 hours of MOC Credit
CNE Credits: Maximum of 1 hours of ANCC Credit
ACPE Credits: ACPE 1 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

    Moderator(s)

  • Carlos Franco-Paredes, MD, MPH

    Faculty
    Department of Medicine - Division of Infectious Diseases
    Hospital Infantil de Mexico, Mexico and Instituto Conmemorativo de la Salud, Panama
    Denver, CO, United States

  • Sapna Bamrah Morris, MD

    Associate Director of Programs
    Centers for Disease Control and Prevention
    Dulles, VA, United States

    • Faculty(s)

  • Dong Heun Lee, MD (he/him/his)

    Professor of Medicine
    Division of Infectious Diseases, Department of Medicine
    University of California San Francisco
    San Francisco, CA, United States

  • Maria Ochoa, MD (she/her/hers)

    Professor Clinical Dermatology
    UNIVERSITY OF SOUTHERN CALIFORNIA, CA, United States

Disclosure(s):
Carlos Franco-Paredes, MD, MPH: No financial relationships to disclose
Sapna Bamrah Morris, MD: No financial relationships to disclose
Dong Heun Lee, MD: No financial relationships to disclose
Maria T. Ochoa, MD: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • explain benefits and risks of standard multidrug therapy versus alternative multidrug regimens in the treatment of leprosy (hansen's disease);
  • describe updates in the management of leprosy reactions.

Presentations:

  • 8:00 AM – 8:30 AM US PT
    Benefits and Risks of Standard Multidrug Therapy versus Alternative Second-Line Drug Regimens for Hansen's disease

    Speaker: Dong Heun Lee, MD (he/him/his) – University of California San Francisco

  • 8:30 AM – 9:00 AM US PT
    Updates in the Management of Leprosy Reactions

    Speaker: Maria T. Ochoa, MD (she/her/hers) – UNIVERSITY OF SOUTHERN CALIFORNIA